Five months after the FDA blocked its plans for accelerated approval, Agenus is moving ahead with discussions with potential ...

Merck's Keytruda and Eisai's Lenvima combo with chemo failed survival endpoint in gastroesophageal cancer study, but ...

Aardvark Therapeutics files for IPO. Company develops hunger-targeting obesity drug ARD-101 and ARD-201, led by CEO Tien Lee.

Moderna’s chief information officer Brad Miller is 'retiring' in February, a company spokesperson confirmed to Endpoints News ...

UnitedHealth Group has named a new CEO to lead its health insurance business, following the murder of the division’s former ...

Takeda has ended the manufacturing and supply of its gout drug Uloric in the US market as more patients turn to generic ...

Teva, Astellas and AstraZeneca say they will participate in the next round of Medicare negotiations under the Inflation ...

President Donald Trump's communications pause for HHS, FDA and other health-related agencies could push some drug approval ...

AstraZeneca is looking to increase its presence north of the US border. The UK pharma said it is budgeting $570 million to ...

Boehringer Ingelheim merges AMAL and ViraTherapeutics cancer units, Dantari sells assets to Adanate, Madrona raises $770M, and Abdera adds JJDC and Foresite as investors.

Purdue Pharma and the Sackler family have agreed to a $7.4 billion settlement in a longstanding legal battle over the ...

ALX Oncology is forging ahead with a treatment approach that has long been abandoned by other drugmakers, eyeing a potential ...